Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01426308 · ClinicalTrials.gov registry record
Method Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test
A clinical trial of Post-natal Cytogenetics, sponsored by Illumina.
- Completed
- Registry status
- 900
- Enrollment target
- 3
- Study locations
NCT01426308: Completed study of Post-natal Cytogenetics, sponsored by Illumina.
NCT01426308 is a study of Post-natal Cytogenetics that has completed, run by Illumina. The registered enrollment target is 900 participants. The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01426308, a study of Post-natal Cytogenetics, has completed, sponsored by Illumina.
- COMPLETED
- Registry status
- 900 participants
- Enrollment target
- 3
- Study locations
Study Summary
The study will determine the performance of the Infinium HD Test. * The primary objective of the study is to assess the performance of the Infinium HD Test using banked DNA samples extracted from whole blood patient samples derived from the intended use population. * The secondary objective of the study is to determine the background number of chromosomal abnormalities per person in the general population based on the resolution of the Infinium HD Test.
Conditions Studied
Study Locations (3)
South Carolina
- Medical University of South Carolina - Charleston
Texas
- Baylor College of Medicine - Houston
Utah
- ARUP Laboratories - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2011-08 |
| Est. Completion | 2011-11 |
What the finished NCT01426308 record still lists
NCT01426308 is an observational study that tracks outcomes without assigning an intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Post-natal Cytogenetics appearing as the primary indexed condition, and to 0 interventions.
NCT01426308 reports a single indexed study location in South Carolina, Texas, Utah.
Frequently Asked Questions
What is clinical trial NCT01426308 about?
NCT01426308 is a clinical study titled "Method Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test". The study will determine the performance of the Infinium HD Test. * The primary objective of the study is to assess the performance of the Infinium HD Test using banked DNA samples extracted from whole blood patient samples derived from the intended use population. * The secondary objective of the ...
What is the current status of trial NCT01426308?
This trial is currently completed. The enrollment target is 900 participants. The study started on 2011-08. Estimated completion is 2011-11.
What conditions does trial NCT01426308 study?
This clinical trial studies the following conditions: Post-natal Cytogenetics.
Who is sponsoring clinical trial NCT01426308?
This trial is sponsored by Illumina, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01426308 being conducted?
This trial has 3 study locations across South Carolina, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- NCT02960022 · 900 participants · Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia